Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 11, Supplement B, 1983   [Index by Author] 


Down Preface
Down Articles
Down Discussion-In-vitro activity
Down Discussion-Pharmacology
Down Discussion-Clinical
Down Summary
Down Index


[Search ALL Issues]


Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

Harold C. Neu, David S. Reeves, and Donald A. Leigh
Preface
J. Antimicrob. Chemother. 1983 11: iii; doi:10.1093/jac/11.suppl_B.iii [PDF] [Request Permissions]  

Articles Back

Harold C. Neu
The role of Pseudomonas aeruginosa in infections
J. Antimicrob. Chemother. 1983 11: 1-13; doi:10.1093/jac/11.suppl_B.1 [Abstract] [PDF] [Request Permissions]  

Michale F. Parry
The in-vitro activity of azlocillin: a community hospital study of 1900 clinical isolates
J. Antimicrob. Chemother. 1983 11: 15-20; doi:10.1093/jac/11.suppl_B.15 [Abstract] [PDF] [Request Permissions]  

Christine C. Sanders
Azlocillin: a new broad spectrum penicillin
J. Antimicrob. Chemother. 1983 11: 21-31; doi:10.1093/jac/11.suppl_B.21 [Abstract] [PDF] [Request Permissions]  

Nai-Xun Chin and Harold C. Neu
Synergy of azlocillin with aminoglycosides
J. Antimicrob. Chemother. 1983 11: 33-38; doi:10.1093/jac/11.suppl_B.33 [Abstract] [PDF] [Request Permissions]  

D. Förster and V. Arndt
Bactericidal activity of mezlocillin and azlocillin
J. Antimicrob. Chemother. 1983 11: 39-41; doi:10.1093/jac/11.suppl_B.39 [PDF] [Request Permissions]  

H. Grimm
In-vitro activity of azlocillin and other β-lactam antibiotics against enterococci
J. Antimicrob. Chemother. 1983 11: 43-49; doi:10.1093/jac/11.suppl_B.43 [Abstract] [PDF] [Request Permissions]  

W. Michael Scheld, James P. Brodeur, John M. Keeley, Mary R. Field, Walter J. Kelly, IV, William J. Long, Jr., and Otokar Zak
Evaluation of azlocillin in-vitro and in discriminative animal models of infection
J. Antimicrob. Chemother. 1983 11: 51-68; doi:10.1093/jac/11.suppl_B.51 [Abstract] [PDF] [Request Permissions]  

W. Eugene Sanders, Jr.
Clinical experience with azlocillin
J. Antimicrob. Chemother. 1983 11: 69-75; doi:10.1093/jac/11.suppl_B.69 [Abstract] [PDF] [Request Permissions]  

Fernando A. Delgado, Robert L. Stout, and Andrew Whelton
Pharmacokinetics of azlocillin in normal renal function: single and repetitive dosing studies
J. Antimicrob. Chemother. 1983 11: 79-88; doi:10.1093/jac/11.suppl_B.79 [Abstract] [PDF] [Request Permissions]  

Andrew Whelton, Robert L. Stout, and Fernando A. Delgado
Azlocillin kinetics during extracorporeal haemodialysis and peritoneal dialysis
J. Antimicrob. Chemother. 1983 11: 89-95; doi:10.1093/jac/11.suppl_B.89 [Abstract] [PDF] [Request Permissions]  

Andrew Whelton, Robert L. Stout, and Fernando A. Delgado
An azlocillin dosing nomogram for renal insufficiency
J. Antimicrob. Chemother. 1983 11: 97-99; doi:10.1093/jac/11.suppl_B.97 [Abstract] [PDF] [Request Permissions]  

Tom Bergan
Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency
J. Antimicrob. Chemother. 1983 11: 101-114; doi:10.1093/jac/11.suppl_B.101 [Abstract] [PDF] [Request Permissions]  

Kurt G. Naber and Dieter Adam
Pharmacokinetics of azlocillin after discontinuous intravenous administration of high dose
J. Antimicrob. Chemother. 1983 11: 115-120; doi:10.1093/jac/11.suppl_B.115 [Abstract] [PDF] [Request Permissions]  

H. Lode, V. Madey, G. Dzwillo, K. Borner, and P. Koeppe
Serum bactericidal activity and kinetics of azlocillin and moxalactam after single and combined administration
J. Antimicrob. Chemother. 1983 11: 121-126; doi:10.1093/jac/11.suppl_B.121 [Abstract] [PDF] [Request Permissions]  

G. Heimann
Pharmacokinetics and clinical aspects of azlocillin in paediatrics
J. Antimicrob. Chemother. 1983 11: 127-135; doi:10.1093/jac/11.suppl_B.127 [Abstract] [PDF] [Request Permissions]  

Harold C. Neu, Elliot L. Francke, Carmen Ortiz-Neu, and Alice S. Prince
The use of azlocillin to treat serious infections
J. Antimicrob. Chemother. 1983 11: 141-147; doi:10.1093/jac/11.suppl_B.141 [Abstract] [PDF] [Request Permissions]  

W. Stille
Broad spectrum β-lactam combinations—a new principle of antibacterial treatment
J. Antimicrob. Chemother. 1983 11: 149-151; doi:10.1093/jac/11.suppl_B.149 [PDF] [Request Permissions]  

S. Olive, W. J. Mogabgab, B. Holmes, B. Pollock, B. Pauling, and R. Beville
Treatment of serious Pseudomonas infections with azlocillin
J. Antimicrob. Chemother. 1983 11: 153-158; doi:10.1093/jac/11.suppl_B.153 [Abstract] [PDF] [Request Permissions]  

Pedro Leal del Rosal
A comparative study of the efficacy and safety of azlocillin and gentamicin in the treatment of serious infections
J. Antimicrob. Chemother. 1983 11: 159-167; doi:10.1093/jac/11.suppl_B.159 [Abstract] [PDF] [Request Permissions]  

Marco A. Gonzalez
A comparison of azlocillin and gentamicin in the treatment of serious infections caused by Pseudomonas aeruginosa
J. Antimicrob. Chemother. 1983 11: 169-174; doi:10.1093/jac/11.suppl_B.169 [Abstract] [PDF] [Request Permissions]  

Jacobo Sabbaj, Miguel Torres, and Luis Loza
Comparative clinical evaluation of azlocillin and gentamicin
J. Antimicrob. Chemother. 1983 11: 175-181; doi:10.1093/jac/11.suppl_B.175 [Abstract] [PDF] [Request Permissions]  

Clair E. Cox
A comparison of azocillin and ticarcillin in the treatment of complicated urinary tract infections
J. Antimicrob. Chemother. 1983 11: 183-188; doi:10.1093/jac/11.suppl_B.183 [Abstract] [PDF] [Request Permissions]  

William P. Reed and Darwin L. Palmer
Comparison of azlocillin and ticarcillin in the treatment of urinary tract infection
J. Antimicrob. Chemother. 1983 11: 189-193; doi:10.1093/jac/11.suppl_B.189 [Abstract] [PDF] [Request Permissions]  

F. John McLaughlin, Wallace J. Mathews, Jr., Denise J. Strieder, Bernadetter Sullivan, and Donald A. Goldmann
Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis
J. Antimicrob. Chemother. 1983 11: 195-203; doi:10.1093/jac/11.suppl_B.195 [Abstract] [PDF] [Request Permissions]  

Nancy N. Huang, Judy Palmer, Helen Keith, Daniel Schidlow, Shirley Braverman, and Maurice Goldberg
Comparative efficacy and tolerance study of azlocillin and carbenicillin in patients with cystic fibrosis: a double blind study
J. Antimicrob. Chemother. 1983 11: 205-214; doi:10.1093/jac/11.suppl_B.205 [Abstract] [PDF] [Request Permissions]  

Peter Schacht, George Arcieri, Horst Bruck, Elizabeth Griffith, Rainer Hullman, and Dieter Tettenborn
International clinical experience with azlocillin
J. Antimicrob. Chemother. 1983 11: 215-222; doi:10.1093/jac/11.suppl_B.215 [Abstract] [PDF] [Request Permissions]  

Michael F. Parry
The tolerance and safety of azlocillin
J. Antimicrob. Chemother. 1983 11: 223-228; doi:10.1093/jac/11.suppl_B.223 [Abstract] [PDF] [Request Permissions]  

Discussion-In-vitro activity Back

Discussion—In-vitro activity
J. Antimicrob. Chemother. 1983 11: 77-78; doi:10.1093/jac/11.suppl_B.77 [PDF] [Request Permissions]  

Discussion-Pharmacology Back

Discussion—Pharmacology
J. Antimicrob. Chemother. 1983 11: 137-140; doi:10.1093/jac/11.suppl_B.137 [PDF] [Request Permissions]  

Discussion-Clinical Back

Discussion—Clinical
J. Antimicrob. Chemother. 1983 11: 229-232; doi:10.1093/jac/11.suppl_B.229 [PDF] [Request Permissions]  

Summary Back

Harold C. Neu
Azlocillin—An antipseudomonas pencillin
J. Antimicrob. Chemother. 1983 11: 233-235; doi:10.1093/jac/11.suppl_B.233 [PDF] [Request Permissions]  

Index Back

Index
J. Antimicrob. Chemother. 1983 11: 237-239; doi:10.1093/jac/11.suppl_B.237 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.